Donald Frail serves as Executive at Pandion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Donald Frail has executed 3 insider transactions totaling $180.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2021 involved transacting 61,113 shares valued at $3.7M.
Donald Frail currently holds 51,113 shares of Pandion Therapeutics, Inc. (PAND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald Frail has been a net buyer of PAND stock. They have purchased $180.0K and sold $0 worth of shares.
Donald Frail's most recent insider trade was on Apr 1, 2021, when they sold 61,113 shares at $60.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 21, 2020 | PAND | $180.0K | Purchase | 10,000 | $18.00 | Discretionary |